Suven Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of March 2025: 6.76%

Suven Pharmaceuticals Limited (SUVENPHAR) has an Asset Resilience Ratio of 6.76% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SUVENPHAR current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs2.05 Billion

≈ $22.17 Million USD Cash + Short-term Investments

Total Assets

Rs30.32 Billion

≈ $327.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Suven Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see SUVENPHAR asset base.

Liquid Assets Composition Over Time

This chart breaks down Suven Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Suven Pharmaceuticals Limited for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.05 Billion	6.76%
Total Liquid Assets	Rs2.05 Billion	6.76%

Asset Resilience Insights

Limited Liquidity: Suven Pharmaceuticals Limited maintains only 6.76% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Suven Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Suven Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Suven Pharmaceuticals Limited (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Suven Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	6.76%	Rs2.05 Billion ≈ $22.17 Million	Rs30.32 Billion ≈ $327.87 Million	-27.57pp
2024-03-31	34.33%	Rs7.74 Billion ≈ $83.69 Million	Rs22.54 Billion ≈ $243.77 Million	+12.84pp
2023-03-31	21.49%	Rs4.22 Billion ≈ $45.68 Million	Rs19.66 Billion ≈ $212.59 Million	-4.81pp
2022-03-31	26.30%	Rs4.81 Billion ≈ $52.04 Million	Rs18.30 Billion ≈ $197.86 Million	+14.05pp
2021-03-31	12.25%	Rs1.81 Billion ≈ $19.53 Million	Rs14.74 Billion ≈ $159.46 Million	+9.63pp
2020-03-31	2.62%	Rs306.76 Million ≈ $3.32 Million	Rs11.73 Billion ≈ $126.84 Million	+1.71pp
2019-03-31	0.90%	Rs70.64 Million ≈ $763.92K	Rs7.83 Billion ≈ $84.68 Million	--

pp = percentage points

About Suven Pharmaceuticals Limited

NSE:SUVENPHAR India Drug Manufacturers - Specialty & Generic

Market Cap

$4.40 Billion

Rs406.97 Billion INR

Market Cap Rank

#3890 Global

#169 in India

Share Price

Rs1063.80

Change (1 day)

+0.00%

52-Week Range

Rs1063.80 - Rs1063.80

All Time High

Rs1334.20